A20 inhibition of NFκB and inflammation: Targeting E2:E3 ubiquitin enzyme complexes

Cell Cycle

Volumn 9, Issue 13, 2010, Pages 2481-2482

  Shembade, Noula ^a   Harhaj, Edward W ^a  

^a UNIVERSITY OF MIAMI   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; LIPOPOLYSACCHARIDE; PROTEIN A20; TAX PROTEIN; TUMOR NECROSIS FACTOR; TUMOR SUPPRESSOR PROTEIN; UBIQUITIN CONJUGATING ENZYME 13; UBIQUITIN CONJUGATING ENZYME E2; UBIQUITIN PROTEIN LIGASE E3; UNCLASSIFIED DRUG; ZINC FINGER PROTEIN;

AUTOIMMUNE DISEASE; CELL SURVIVAL; DNA POLYMORPHISM; EDITORIAL; HUMAN; IMMUNE RESPONSE; INFLAMMATION; NEOPLASM; NONHUMAN; PROTEIN DOMAIN; PROTEIN PROTEIN INTERACTION; PROTEIN TARGETING; UBIQUITINATION;

EID: 77955443665     PISSN: 15384101     EISSN: 15514005     Source Type: Journal    
DOI: 10.4161/cc.9.13.12269     Document Type: Editorial

References (11)

1. Lee EG, Boone DL, Chai S, Libby SL, Chien M, Lodolce JP, et al. Failure to regulate TNF-induced NFκB and cell death responses in A20-deficient mice. Science 2000; 289:2350-4.
2. Coornaert B, Carpentier I, Beyaert R. A20: Central gatekeeper in inflammation and immunity. J Biol Chem 2008.
3. Compagno M, Lim WK, Grunn A, Nandula SV, Brahmachary M, Shen Q, et al. Mutations of multiple genes cause deregulation of NFκB in diffuse large B-cell lymphoma. Nature 2009; 459:717-21.
4. Evans PC, Ovaa H, Hamon M, Kilshaw PJ, Hamm S, Bauer S, et al. Zinc-finger protein A20, a regulator of inflammation and cell survival, has de-ubiquitinating activity. Biochem J 2004; 378:727-34. (Pubitemid 38406847)
5. Wertz IE, O'Rourke KM, Zhou H, Eby M, Aravind L, Seshagiri S, et al. De-ubiquitination and ubiquitin ligase domains of A20 downregulate NFκB signalling. Nature 2004; 430:694-9. (Pubitemid 39061687)
6. Lin SC, Chung JY, Lamothe B, Rajashankar K, Lu M, Lo YC, et al. Molecular basis for the unique deubiquitinating activity of the NFκB inhibitor A20. J Mol Biol 2008; 376:526-40.
7. Shembade N, Harhaj NS, Parvatiyar K, Copeland NG, Jenkins NA, Matesic LE, et al. The E3 ligase Itch negatively regulates inflammatory signaling pathways by controlling the function of the ubiquitin-editing enzyme A20. Nat Immunol 2008; 9:254-62. (Pubitemid 351276830)
8. Shembade N, Parvatiyar K, Harhaj NS, Harhaj EW. The ubiquitin-editing enzyme A20 requires RNF11 to downregulate NFκB signalling. EMBO J 2009; 28:513-22.
9. Shembade N, Ma A, Harhaj EW. Inhibition of NFκB Signaling by A20 Through Disruption of Ubiquitin Enzyme Complexes. Science 2010; 327:1135-9.
10. Lee S, Tsai YC, Mattera R, Smith WJ, Kostelansky MS, Weissman AM, et al. Structural basis for ubiquitin recognition and autoubiquitination by Rabex-5. Nat Struct Mol Biol 2006; 13:264-71. (Pubitemid 43348513)
11. Shembade N, Harhaj NS, Yamamoto M, Akira S, Harhaj EW. The human T-cell leukemia virus type 1 Tax oncoprotein requires the ubiquitin-conjugating enzyme Ubc13 for NFκB activation. J Virol 2007; 81:13735-42. (Pubitemid 350247866)